Therapy Areas: Cardiovascular
28 March 2024 - US-based screening and early detection specialist Polymedco LLC announced on Wednesday that it has received US Food and Drug Administration (FDA) approval for the PATHFAST high-sensiti...
15 March 2024 - Gilgamesh Pharmaceuticals, a clinical-stage neuroscience company, announced on Thursday that it has received a multi-year USD14m grant from National Institute on Drug Abuse (NIDA).The ...
13 March 2024 - Advanced Medical Solutions Group plc (AIM: AMS), a provider of tissue-healing technologies, declared on Wednesday that it plans to acquire Peters Surgical, a global provider of surgica...
13 March 2024 - Biopharmaceutical company AstraZeneca (LSE: AZN) announced on Wednesday that it has initiated THARROS, a groundbreaking Phase III trial exploring the potential of BREZTRI AEROSPHERE to...
13 March 2024 - Biotechnology company Silence Therapeutics (Nasdaq: SLN) on Wednesday disclosed positive topline 36-week data from the ongoing ALPACAR-360 phase 2 study of zerlasiran (SLN360). Zerlasi...
1 March 2024 - Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), a United States-based biotechnology company, announced on Thursday that it has named Kyle Jenne as its new executive vice president, chief gl...